ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 44585 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 44585; 2) Community: the network communities that were significantly associated with the response to NSC 44585; 3) Molecule: the relationships between components within communities and NSC 44585; 4) MDR: the compounds that were significantly associated with the NSC 44585.

NSC Compound Enrichment Correlation
NSC 708423 Null 0.0342636096654271 0.11250854
NSC 710549 Null 0.0342636096654271 -0.19674348
NSC 714604 Purpureagitosid 0.0342636096654271 0.13980804
NSC 719715 Null 0.0342636096654271 0.19282841
NSC 721049 7Z-Plakortide H 0.0342636096654271 0.13424085
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0342636096654271 0.34009635
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0342636096654271 0.27865636
NSC 747461 Null 0.0342636096654271 0.14178411
NSC 748715 Null 0.0342636096654271 0.23880766
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0342636096654271 -0.037745841
Total:76  Current:56    [First] [Prev] [Next] [Last]